A Study With Tasquinimod Treating Patients With Hepatocellular, Ovarian, Renal Cell and Gastric Cancers
Status:
Completed
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
This was an exploratory proof of concept study to determine the clinical activity of
tasquinimod in patients with advanced or metastatic hepatocellular carcinoma, ovarian
carcinoma, renal cell carcinoma and gastric carcinoma who had progressed after standard
therapies.